February 11, 2015
Spellman DS et al. Prot Clin Appl 2015;9:715-731.
Development and Evaluation of a Multiplexed Mass Spectrometry-Based Assay for Measuring Candidate Peptide Biomarkers in Alzheimer’s Disease Neuroimaging Initiative (ADNI) CSF
You might also be interested by
Webcasts & Webinars
Precision Oncology Approaches: Using Proteomics to Build Next-Gen Diagnostic Solutions
May 2, 2023
Proteomics/Mass Spectrometry
More infoPosters
Analytical characterization of a multiplex panel measuring 45 cytokines by proximity extension assay in plasma from subjects with NSCLC
April 17, 2023
Proteomics/Mass Spectrometry
More info